比较急性基底动脉闭塞一线抽吸取栓与支架取栓的功能结局和安全性:PC-SEARCH取栓登记处的倾向性分析
基于PC-SEARCH取栓登记处的回顾性分析,纳入383例急性基底动脉闭塞患者,比较一线抽吸导管与支架取栓的结局。倾向性匹配后,90天功能独立(改良Rankin量表0-3分)两组无显著差异;抽吸组穿刺至再通时间更短、转换技术率更高,支架取栓组症状性颅内出血率更高。
要点
- 一线抽吸与支架取栓的90天功能独立比例无显著差异。
- 倾向匹配后抽吸组穿刺至再通时间18分钟,短于支架取栓组52分钟。
- 支架取栓组症状性颅内出血率9.8%,高于抽吸组3.4%。
核心结论
- 一线抽吸与支架取栓方法在急性基底动脉闭塞患者中显示出相似的功能结局和再通率。
- 支架取栓方法与更高的症状性颅内出血率相关,而抽吸方法与更高的转换至其他技术率相关。
研究设计与样本
- 为PC-SEARCH取栓登记处的回顾性分析,纳入2015年1月至2021年12月连续接受机械取栓的急性基底动脉闭塞患者。
- 共383例患者纳入分析,其中一线抽吸组219例,一线支架取栓组164例;平均年龄65.5岁(SD 15),男性228例(59%)。
- 根据基线特征不平衡进行倾向性分析,比较90天功能结局、术中指标和安全性指标。
主要发现
- 有利功能结局比例在倾向匹配前两组相似(47.3% vs 42.5%;OR 1.22,95%CI 0.78-1.89;P=0.38),匹配后亦无显著差异(OR 1.46,95%CI 0.85-2.49;P=0.17)。
- 倾向匹配队列中,穿刺至再通时间抽吸组18分钟 vs 支架取栓组52分钟(P<0.01),支持一线抽吸。
- 倾向匹配队列中,首过再通率抽吸组43.5% vs 支架取栓组44.5%(P=0.90),两组相似。
- 一线抽吸组转换至其他取栓装置率22% vs 支架取栓组6%(P<0.01),抽吸组更高。
- 支架取栓组症状性颅内出血率9.8% vs 抽吸组3.4%(P=0.04),支架取栓组更高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Aspiration catheters (ASPs) and stentriever thrombectomy devices have comparable safety and efficacy in anterior circulation ischemic strokes. However, there is lack of high-quality comparative data in acute basilar artery occlusions. Our objective is to compare the outcomes and safety of ASPs and stentriever devices in acute basilar artery occlusions. METHODS: This is an analysis of the retrospectively established PC-SEARCH Thrombectomy (Posterior-Circulation Ischemic Stroke Evaluation: Analyzing Radiographic and Intraprocedural Predictors for Mechanical Thrombectomy) registry. Patients were dichotomized based on their first-line thrombectomy device (ASP and stentriever) and associated with their 90-day functional outcomes, intraprocedural metrics, and safety measures. Propensity analysis based on unequal baseline characteristics was performed. Consecutive patients with acute basilar artery occlusions who received mechanical thrombectomy were included from January 2015 to December 2021. Patients received either first-line contact aspiration or stentriever mechanical thrombectomy. Primary clinical and safety outcomes were 90-day functional independence measured by a modified Rankin Scale score of 0 to 3 and symptomatic intracranial hemorrhage, respectively. Secondary outcomes included puncture-recanalization times, first-pass recanalization rates, crossovers to other thrombectomy device, and neurological/hospital complications. RESULTS: Five hundred eighteen patients were included in the registry, and a total of 383 patients were included (mean [SD] age, 65.5 [15] years; 228 [59%] men) in this analysis. Of these, 219 patients were first-line ASP while 164 patients received first-line stentriever devices. Median premorbid modified Rankin Scale was zero and median presenting National Institutes of Health Stroke Scale was 17 (interquartile range, 8-26). The proportion of favorable functional outcome was similar between the 2 techniques before (47.3% versus 42.5%; odds ratio, 1.22 [95% CI, 0.78-1.89]; P=0.38) and after propensity matching (odds ratio, 1.46 [95% CI, 0.85-2.49]; P=0.17). In our propensity-matched cohorts, puncture-recanalization times (18 versus 52 minutes; P<0.01) favored first-line ASP; however, first-pass recanalization rates (43.5% versus 44.5%; P=0.90) were similar between groups. First-line ASP was associated with higher rates of crossover (22% versus 6%; P<0.01), whereas stentriever was associated with higher rates of symptomatic intracranial hemorrhage (9.8% versus 3.4%; P=0.04). CONCLUSIONS: First-line ASP and stentriever methods demonstrated similar functional outcome and recanalization rates. Stentriever methods were associated with higher rates of symptomatic intracranial hemorrhage, whereas ASPs were associated with higher rates of crossover to alternative technique in patients with acute basilar occlusions.
引用
- Mierzwa AT, Al Kasab S, Nelson A, et al. Comparing Functional Outcomes and Safety Profiles of First-Line Aspiration Thrombectomy Versus Stentriever for Acute Basilar Artery Occlusion: Propensity Analysis of the PC-SEARCH Thrombectomy Registry. Stroke. 2023. PMID: 37747965. doi:10.1161/STROKEAHA.123.043579
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。